[ Price : $8.95]
Federal Register notice: FDA seeks comments on the abuse potential, medical usefulness, trafficking, and impact of scheduling chan...[ Price : $8.95]
Federal Register notice: FDA announces a 10/7 Science Board Advisory Committee meeting that will hear an update from the new Alter...[ Price : $8.95]
Two stakeholders call on FDA to make major changes to a draft guidance on the REMS logic model that is intended to link program de...[ Price : $8.95]
The drug development consulting firm Rahaa asks FDA to require stability studies under refrigerated conditions for generic version...[ Price : $8.95]
Federal Register notice: FDA renews for two years its Peripheral and Central Nervous System Drugs advisory committee.[ Price : $8.95]
FDA approves a Galderma BLA for Nemluvio (nemolizumab), a pre-filled pen for subcutaneous injection for adults with prurigo nodula...[ Price : $8.95]
FDA warns Lublin, Poland, physician Konrad Rejdak about Bioresearch Monitoring violations in a clinical study for which he was the...[ Price : $8.95]
FDA warns Jordans Nowrez and Ismail Shukri Company about CGMP violations in the production of OTC drugs.